Abstract
600 ORAL Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC), an interim safety analysis. a Dutch Colorectal Cancer Group (DCCG) phase III study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have